Clinical consequences of generic warfarin substitution: an ecological study.
暂无分享，去创建一个
[1] D. Witt,et al. Evaluation of the Clinical and Economic Impact of a Brand Name—to‐Generic Warfarin Sodium Conversion Program , 2003, Pharmacotherapy.
[2] Kathryn A Phillips,et al. Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 19972000 , 2005, Annals of Internal Medicine.
[3] E. Nutescu,et al. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers. , 2004, Seminars in thrombosis and hemostasis.
[4] Paul Grootendorst,et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. , 2003, The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique.
[5] U Helfenstein,et al. Box-Jenkins modelling in medical research , 1996, Statistical methods in medical research.
[6] H. Halkin,et al. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching , 2003, Clinical pharmacology and therapeutics.
[7] A. Forster,et al. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. , 2006, Thrombosis research.
[8] B. Reeder,et al. Validity of Stroke Diagnosis on Hospital Discharge Records in Saskatchewan, Canada: Implications for Stroke Surveillance , 1999, Cerebrovascular Diseases.